T2D development is closely associated with obesity-induced inflammation, which impairs insulin sensitivity by damaging pancreatic beta cells, ultimately leading to insulin resistance [47]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.